Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer

References

• McClintockBThe behavior in successive nuclear divisions of a chromosome broken at meiosisProc Natl Acad Sci U S A193925840541616577924
   PubMedGoogle Scholar
• MullerHJThe remaking of chromosomesCollecting Net19388182195
   Google Scholar
• BlackburnEHGallJGA tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in TetrahymenaJ Mol Biol197812013353642006
   PubMed Web of Science ®Google Scholar
• MoyzisRKBuckinghamJMCramLSA highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomesProc Natl Acad Sci U S A19888518662266263413114
   PubMed Web of Science ®Google Scholar
• David WilsonWPaulAKinetics and structures on the molecular path to the quadruplex form of the human telomereJ Mol Biol201442681625162824508600
   PubMed Web of Science ®Google Scholar
• GriffithJDComeauLRosenfieldSMammalian telomeres end in a large duplex loopCell199997450351410338214
   PubMed Web of Science ®Google Scholar
• XuLLiSStohrBAThe role of telomere biology in cancerAnnu Rev Pathol20138497822934675
   PubMed Web of Science ®Google Scholar
• RudenMPuriNNovel anticancer therapeutics targeting telomeraseCancer Treat Rev201339544445622841437
   PubMed Web of Science ®Google Scholar
• RaySBandariaJNQureshiMHYildizABalciHG-quadruplex formation in telomeres enhances POT1/TPP1 protection against RPA bindingProc Natl Acad Sci U S A201411182990299524516170
   PubMed Web of Science ®Google Scholar
• AllsoppRCVaziriHPattersonCTelomere length predicts replicative capacity of human fibroblastsProc Natl Acad Sci U S A1992892110114101181438199
   PubMed Web of Science ®Google Scholar
• BrownJPWeiWSedivyJMBypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblastsScience199727753278318349242615
   PubMed Web of Science ®Google Scholar
• HarleyCBFutcherABGreiderCWTelomeres shorten during ageing of human fibroblastsNature199034562744584602342578
   PubMed Web of Science ®Google Scholar
• de LangeTActivation of telomerase in a human tumorProc Natl Acad Sci U S A1994918288228858159672
   PubMed Web of Science ®Google Scholar
• KimNWPiatyszekMAProwseKRSpecific association of human telomerase activity with immortal cells and cancerScience19942665193201120157605428
   PubMed Web of Science ®Google Scholar
• NakamuraTMMorinGBChapmanKBTelomerase catalytic subunit homologs from fission yeast and humanScience199727753289559599252327
   PubMed Web of Science ®Google Scholar
• Shippen-LentzDBlackburnEHFunctional evidence for an RNA template in telomeraseScience199024749425465521689074
   PubMed Web of Science ®Google Scholar
• CesareAJReddelRRAlternative lengthening of telomeres: models, mechanisms and implicationsNat Rev Genet201011531933020351727
   PubMed Web of Science ®Google Scholar
• HensonJDHannayJAMcCarthySWA robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomasClin Cancer Res200511121722515671549
   PubMed Web of Science ®Google Scholar
• JohnsonJEVarkonyiRJSchwalmJMultiple mechanisms of telomere maintenance exist in liposarcomasClin Cancer Res200511155347535516061847
   PubMed Web of Science ®Google Scholar
• QueisserAHeegSThalerMvon WerderAOpitzOGInhibition of telomerase induces alternative lengthening of telomeres during human esophageal carcinogenesisCancer Genet20132061137438624331919
   PubMed Web of Science ®Google Scholar
• DanielMPeekGWTollefsbolTORegulation of the human catalytic subunit of telomerase (hTERT)Gene2012498213514622381618
   PubMed Web of Science ®Google Scholar
• KyoSTakakuraMTairaTSp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT)Nucleic Acids Res200028366967710637317
   PubMed Web of Science ®Google Scholar
• ChouCKLeeDFSunHLThe suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcriptionMol Carcinog200948111048105819526459
   PubMed Web of Science ®Google Scholar
• ZhuJBlenisJYuanJActivation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1Proc Natl Acad Sci U S A2008105186584658918451027
   PubMed Web of Science ®Google Scholar
• GoueliBSJanknechtRUpregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or RafMol Cell Biol2004241253514673140
   PubMed Web of Science ®Google Scholar
• HeegSHirtNQueisserAEGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesisCancer Sci2011102235136021156006
   PubMed Web of Science ®Google Scholar
• HorikawaICablePLMazurSJAppellaEAfshariCABarrettJCDownstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repressionMol Biol Cell20021382585259712181331
   PubMed Web of Science ®Google Scholar
• LiuLLaiSAndrewsLGTollefsbolTOGenetic and epigenetic modulation of telomerase activity in development and diseaseGene2004340111015556289
   PubMed Web of Science ®Google Scholar
• LiuLSaldanhaSNPateMSAndrewsLGTollefsbolTOEpigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiationGenes Chromosomes Cancer2004411263715236314
   PubMed Web of Science ®Google Scholar
• ShinKHKangMKDicterowEParkNHHypermethylation of the hTERT promoter inhibits the expression of telomerase activity in normal oral fibroblasts and senescent normal oral keratinocytesBr J Cancer20038981473147814562019
   PubMed Web of Science ®Google Scholar
• ZhuJZhaoYWangSChromatin and epigenetic regulation of the telomerase reverse transcriptase geneProtein Cell201011223221203995
   PubMed Web of Science ®Google Scholar
• GuilleretIYanPGrangeFBraunschweigRBosmanFTBenhattarJHypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activityInt J Cancer2002101433534112209957
   PubMed Web of Science ®Google Scholar
• RenaudSLoukinovDAbdullaevZDual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT geneNucleic Acids Res20073541245125617267411
   PubMed Web of Science ®Google Scholar
• ZinnRLPruittKEguchiSBaylinSBHermanJGhTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start siteCancer Res200767119420117210699
   PubMed Web of Science ®Google Scholar
• DevereuxTRHorikawaIAnnaCHAnnabLAAfshariCABarrettJCDNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) geneCancer Res199959246087609010626795
   PubMed Web of Science ®Google Scholar
• CongYSWrightWEShayJWHuman telomerase and its regulationMicrobiol Mol Biol Rev2002663407425 table of contents12208997
   PubMed Web of Science ®Google Scholar
• KangSSKwonTKwonDYDoSIAkt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunitJ Biol Chem199927419130851309010224060
   PubMed Web of Science ®Google Scholar
• ChangJTLuYCChenYJhTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cellsBr J Cancer200694687087816508638
   PubMed Web of Science ®Google Scholar
• LiHZhaoLYangZFunderJWLiuJPTelomerase is controlled by protein kinase Calpha in human breast cancer cellsJ Biol Chem19982735033436334429837921
   PubMed Web of Science ®Google Scholar
• KharbandaSKumarVDharSRegulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinaseCurr Biol2000101056857510837221
   PubMed Web of Science ®Google Scholar
• TomlinsonRLZieglerTDSupakorndejTTernsRMTernsMPCell cycle-regulated trafficking of human telomerase to telomeresMol Biol Cell200617295596516339074
   PubMed Web of Science ®Google Scholar
• HoltSEAisnerDLBaurJFunctional requirement of p23 and Hsp90 in telomerase complexesGenes Dev199913781782610197982
   PubMed Web of Science ®Google Scholar
• BryanTMEnglezouAGuptaJBacchettiSReddelRRTelomere elongation in immortal human cells without detectable telomerase activityEMBO J19951417424042487556065
   PubMed Web of Science ®Google Scholar
• ChungIOsterwaldSDeegKIRippeKPML body meets telomere: the beginning of an ALTernate ending?Nucleus20123326327522572954
   PubMed Web of Science ®Google Scholar
• YeagerTRNeumannAAEnglezouAHuschtschaLINobleJRReddelRRTelomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) bodyCancer Res199959174175417910485449
   PubMed Web of Science ®Google Scholar
• DunhamMANeumannAAFaschingCLReddelRRTelomere maintenance by recombination in human cellsNat Genet200026444745011101843
   PubMed Web of Science ®Google Scholar
• MurnaneJPSabatierLMarderBAMorganWFTelomere dynamics in an immortal human cell lineEMBO J19941320495349627957062
   PubMed Web of Science ®Google Scholar
• LeSMooreJKHaberJEGreiderCWRAD50 and RAD51 define two pathways that collaborate to maintain telomeres in the absence of telomeraseGenetics1999152114315210224249
   PubMed Web of Science ®Google Scholar
• TarsounasMMuñozPClaasATelomere maintenance requires the RAD51D recombination/repair proteinCell2004117333734715109494
   PubMed Web of Science ®Google Scholar
• CesareAJGriffithJDTelomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loopsMol Cell Biol200424229948995715509797
   PubMed Web of Science ®Google Scholar
• HensonJDReddelRRAssaying and investigating alternative lengthening of telomeres activity in human cells and cancersFEBS Lett2010584173800381120542034
   PubMed Web of Science ®Google Scholar
• GochaARHarrisJGrodenJAlternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progressionMutat Res2013743744142150
   Web of Science ®Google Scholar
• HuJHwangSSLiesaMAntitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancerCell2012148465166322341440
   PubMed Web of Science ®Google Scholar
• GochaARNuovoGIwenofuOHGrodenJHuman sarcomas are mosaic for telomerase-dependent and telomerase-independent telomere maintenance mechanisms: implications for telomere-based therapiesAm J Pathol20131821414823260199
   PubMed Web of Science ®Google Scholar
• YuHPXuSQLuWHTelomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagusJ Surg Oncol20048629910415112252
   PubMed Web of Science ®Google Scholar
• ZhengYLHuNSunQWangCTaylorPRTelomere attrition in cancer cells and telomere length in tumor stroma cells predict chromosome instability in esophageal squamous cell carcinoma: a genome-wide analysisCancer Res20096941604161419190333
   PubMed Web of Science ®Google Scholar
• QuanteMHeegSvon WerderADifferential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesisCarcinogenesis200526111879188915958520
   PubMed Web of Science ®Google Scholar
• ZhaoYGaoYChenZHuXZhouFHeJLow frequency of TERT promoter somatic mutation in 313 sporadic esophageal squamous cell carcinomasInt J Cancer2014134249349423818232
   PubMed Web of Science ®Google Scholar
• van NistelrooijAMZwarthoffECPostEAbsence of TERT promoter mutations in esophageal adenocarcinomaInt J Cancer201413482014201524493128
   PubMed Web of Science ®Google Scholar
• FinleyJCReidBJOdzeRDChromosomal instability in Barrett’s esophagus is related to telomere shorteningCancer Epidemiol Biomarkers Prev20061581451145716896031
   PubMed Web of Science ®Google Scholar
• LordRVSalongaDDanenbergKDTelomerase reverse transcriptase expression is increased early in the Barrett’s metaplasia, dysplasia, adenocarcinoma sequenceJ Gastrointest Surg20004213514210675236
   PubMed Web of Science ®Google Scholar
• MoralesCPLeeELShayJWIn situ hybridization for the detection of telomerase RNA in the progression from Barrett’s esophagus to esophageal adenocarcinomaCancer19988346526599708927
   PubMed Web of Science ®Google Scholar
• PapanikolaouVIliopoulosDDimouIThe involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cellsInt J Oncol20093551141114919787269
   PubMed Web of Science ®Google Scholar
• HouLSavageSABlaserMJTelomere length in peripheral leukocyte DNA and gastric cancer riskCancer Epidemiol Biomarkers Prev200918113103310919861514
   PubMed Web of Science ®Google Scholar
• BasuNSkinnerHGLitzelmanKVanderboomRBaichooEBoardmanLATelomeres and telomere dynamics: relevance to cancers of the GI tractExpert Rev Gastroenterol Hepatol20137873374824161135
   PubMed Web of Science ®Google Scholar
• HuangDSWangZHeXJRecurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activationEur J Cancer201551896997625843513
   PubMed Web of Science ®Google Scholar
• SasakiTKuniyasuHLuoYAKT activation and telomerase reverse transcriptase expression are concurrently associated with prognosis of gastric cancerPathobiology2014811364123969493
   PubMed Web of Science ®Google Scholar
• NaitoYTakagiTHandaOTelomerase activity and expression of telomerase RNA component and catalytic subunits in precancerous and cancerous colorectal lesionsTumour Biol200122637438211786731
   PubMedGoogle Scholar
• EngelhardtMDrullinskyPGuillemJMooreMATelomerase and telomere length in the development and progression of premalignant lesions to colorectal cancerClin Cancer Res1997311193119419815582
   PubMed Web of Science ®Google Scholar
• RampazzoEBertorelleRSerraLRelationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancersBr J Cancer201010281300130520386541
   PubMed Web of Science ®Google Scholar
• GertlerRRosenbergRStrickerDTelomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinomaJ Clin Oncol200422101807181415143073
   PubMed Web of Science ®Google Scholar
• BertorelleRRampazzoEPucciarelliSNittiDDe RossiATelomeres, telomerase and colorectal cancerWorld J Gastroenterol20142081940195024616570
   PubMed Web of Science ®Google Scholar
• BertorelleRBriaravaMRampazzoETelomerase is an independent prognostic marker of overall survival in patients with colorectal cancerBr J Cancer2013108227828423322193
   PubMed Web of Science ®Google Scholar
• WegeHBrummendorfTHTelomerase activation in liver regeneration and hepatocarcinogenesis: Dr Jekyll or Mr Hyde?Curr Stem Cell Res Ther200721313818220890
   PubMedGoogle Scholar
• OhBKKimYJParkYNChoiJKimKSParkCQuantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesisAm J Gastroenterol2006101483183816494581
   PubMed Web of Science ®Google Scholar
• NaultJCMalletMPilatiCHigh frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesionsNat Commun20134221823887712
   PubMed Web of Science ®Google Scholar
• NaultJCCalderaroJDi TommasoLTelomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosisHepatology20146061983199225123086
   PubMed Web of Science ®Google Scholar
• MiuraNOsakiYNagashimaMA novel biomarker TERTmRNA is applicable for early detection of hepatomaBMC Gastroenterol2010104620482774
   PubMed Web of Science ®Google Scholar
• MizumotoKTanakaMDetection of telomerase activity in patients with pancreatic cancerMethods Mol Med200510319920515542908
   PubMedGoogle Scholar
• VinagreJPintoVCelestinoRTelomerase promoter mutations in cancer: an emerging molecular biomarker?Virchows Arch2014465211913325048572
   PubMed Web of Science ®Google Scholar
• BeattyGLVonderheideRHTelomerase as a universal tumor antigen for cancer vaccinesExpert Rev Vaccines20087788188718767939
   PubMed Web of Science ®Google Scholar
• ShammasMAQaziABatchuRBTelomere maintenance in laser capture microdissection-purified Barrett’s adenocarcinoma cells and effect of telomerase inhibition in vivoClin Cancer Res200814154971498018676772
   PubMed Web of Science ®Google Scholar
• WuXSmavadatiSNordfjällKTelomerase antagonist imetelstat inhibits esophageal cancer cell growth and increases radiation-induced DNA breaksBiochim Biophys Acta20121823122130213522906540
   PubMed Web of Science ®Google Scholar
• DjojosubrotoMWChinACGoNTelomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatomaHepatology20054251127113616114043
   PubMed Web of Science ®Google Scholar
• JosephITresslerRBassettEThe telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell linesCancer Res201070229494950421062983
   PubMed Web of Science ®Google Scholar
• LuRPalJBuonLTargeting homologous recombination and telomerase in Barrett’s adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growthOncogene201433121495150523604115
   PubMed Web of Science ®Google Scholar
• GretenTFFornerAKorangyFA phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinomaBMC Cancer20101020920478057
   PubMed Web of Science ®Google Scholar
• BernhardtSLGjertsenMKTrachselSTelomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II studyBr J Cancer200695111474148217060934
   PubMed Web of Science ®Google Scholar
• ChoudhuryAMosolitsSKokhaeiPHanssonLPalmaMMellstedtHClinical results of vaccine therapy for cancer: learning from history for improving the futureAdv Cancer Res20069514720216860658
   PubMed Web of Science ®Google Scholar
• MiddletonGSilcocksPCoxTGemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trialLancet Oncol201415882984024954781
   PubMed Web of Science ®Google Scholar
• LinWHYehSHYangWJTelomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic miceInt J Cancer201313261451146222886913
   PubMed Web of Science ®Google Scholar
• WirthTKühnelFFleischmann-MundtBTelomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1Cancer Res200565167393740216103092
   PubMed Web of Science ®Google Scholar
• MoserCLangSAStoeltzingOHeat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancerAnticancer Res20092962031204219528462
   PubMed Web of Science ®Google Scholar
• JavleMCurtinNJThe role of PARP in DNA repair and its therapeutic exploitationBr J Cancer201110581114112221989215
   PubMed Web of Science ®Google Scholar
• WaalerJMachonOTumovaLA novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant miceCancer Res201272112822283222440753
   PubMed Web of Science ®Google Scholar